Estimating latent tuberculosis infection using interferon-γ release assay, Japan

Tomoyasu Nishimura; Masaki Ota; Masaaki Mori; Naoki Hasegawa; Hiroshi Kawabe; Seiya Kato

doi:10.3201/eid2411.171948

Estimating latent tuberculosis infection using interferon-γ release assay, Japan

Tomoyasu Nishimura, Masaki Ota, Masaaki Mori, Naoki Hasegawa, Hiroshi Kawabe, Seiya Kato

研究成果: Letter › 査読

本文言語	English
ページ（範囲）	2111-2113
ページ数	3
ジャーナル	Emerging Infectious Diseases
巻	24
号	11
DOI	https://doi.org/10.3201/eid2411.171948
出版ステータス	Published - 2018 11月

ASJC Scopus subject areas

疫学
微生物学（医療）
感染症

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.3201/eid2411.171948

他のファイルとリンク

引用スタイル

@article{616e724faaf746af9c94adc7d18d6423,

title = "Estimating latent tuberculosis infection using interferon-γ release assay, Japan",

author = "Tomoyasu Nishimura and Masaki Ota and Masaaki Mori and Naoki Hasegawa and Hiroshi Kawabe and Seiya Kato",

note = "Funding Information: We are grateful to Satoshi Mitarai for his critical reading of our manuscript. This research was supported by the Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development (JP17fk0108304) and Keio Gijuku Academic Development Funds. This research study was completed as part of our collaborative research with Oxford Immunotec, Ltd. (Abington, UK).",

year = "2018",

month = nov,

doi = "10.3201/eid2411.171948",

language = "English",

volume = "24",

pages = "2111--2113",

journal = "Emerging Infectious Diseases",

issn = "1080-6040",

publisher = "Centers for Disease Control and Prevention (CDC)",

number = "11",

}

TY - JOUR

T1 - Estimating latent tuberculosis infection using interferon-γ release assay, Japan

AU - Nishimura, Tomoyasu

AU - Ota, Masaki

AU - Mori, Masaaki

AU - Hasegawa, Naoki

AU - Kawabe, Hiroshi

AU - Kato, Seiya

N1 - Funding Information: We are grateful to Satoshi Mitarai for his critical reading of our manuscript. This research was supported by the Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development (JP17fk0108304) and Keio Gijuku Academic Development Funds. This research study was completed as part of our collaborative research with Oxford Immunotec, Ltd. (Abington, UK).

PY - 2018/11

Y1 - 2018/11

UR - http://www.scopus.com/inward/record.url?scp=85055075421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055075421&partnerID=8YFLogxK

U2 - 10.3201/eid2411.171948

DO - 10.3201/eid2411.171948

M3 - Letter

C2 - 30334726

AN - SCOPUS:85055075421

SN - 1080-6040

VL - 24

SP - 2111

EP - 2113

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

IS - 11

ER -